PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1019140
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1019140
Global Pet Cancer Therapeutics Market Size study, by Therapy, by Animal, by Application, and Regional Forecasts 2021-2027
Contact us about how to customize the report with add-on data.
Global pet cancer therapeutics marketis expected to reach $432.8 million by 2027. Global pet cancer therapeutics market is valued approximately at $226.25 million in 2020 and is anticipated to grow with a healthy growth rate of about 9.71% over the forecast period 2021-2027. Pet cancer therapeutics deals with the novel anti-cancer drugsthat are used in the cancer treatment and is capableof suppressingeffects of cancerous cells and restricttheir growth in animals such as cats, dogs, etc. The global pet cancer therapeutics marketis being driven by prevalence of several types of cancers in cats and dogs and increase in animal health awareness. Furthermore, there have been different initiatives taken place for research and developmentregarding pet cancer management whichwill provide new opportunities for the global pet cancer therapeutics industry. For instance, according to the American Association for the Advancement of Science, in 2021, a research driven pharmaceutical company named Merck Animal Health has granted $0.1 million to Morris Animal Foundation to support research in animal cancer that would help to advance animal cancer care. Also, in 2017, the University of Queensland received a grant worth $2.5 million from the Australian Cancer Research Foundation (ACRF)for the examination of effects of small doses of anti-cancer drugs in animal as well as human cancers at a cellular level.Such research and development activities related topet cancer management is expected to drive the market by increasing the adoption of pet cancer therapeutics. However,side effects caused by drugs used for the treatment of pet cancersmay impede market growth over the forecast period of 2021-2027.
The regional analysis of the global pet cancer therapeutics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share due to increasing pet adoption, growth in per capita animal healthcare expenditure, prevalence of different animal diseases and injuries, etc. in the region. Whereas Asia Pacific is anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to growing awareness as well as availability of different pet cancer medicine etc. across the region.
Major market player included in this report are:
AB Science
AdvaVet Inc.
Boehringer Ingelheim GmbH (Merial)
Elanco
ELIAS Animal Health
Karyopharm Therapeutics, Inc.
Rhizen Pharmaceuticals SA
Torigen Pharmaceuticals Inc.
VetDC Inc.
Virbac
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Therapy:
Chemotherapy
Radiation therapy
Immunotherapy
Others
By Animal:
Dogs
Cats
Others
By Application:
Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.
Target Audience of the Global Pet Cancer Therapeutics Marketin Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Million)
- 1.2.1. Pet Cancer Therapeutics Market, by Region, 2019-2027 (USD Million)
- 1.2.2. Pet Cancer Therapeutics Market, by Therapy,2019-2027 (USD Million)
- 1.2.3. Pet Cancer Therapeutics Market, by Animal,2019-2027 (USD Million)
- 1.2.4. Pet Cancer Therapeutics Market, by Application, 2019-2027 (USD Million)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Pet Cancer Therapeutics Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Pet Cancer Therapeutics Market Dynamics
- 3.1. Pet Cancer Therapeutics Market Impact Analysis (2019-2027)
- 3.1.1. Market Drivers
- 3.1.1.1. Prevalence of several types of cancers in cats and dogs
- 3.1.1.2. Increase in animal health awareness
- 3.1.2. Market Restraint
- 3.1.2.1. Side effects caused by drugs used for the treatment of pet cancers
- 3.1.3. Market Opportunities
- 3.1.3.1. R&D initiatives regarding pet cancer management
- 3.1.1. Market Drivers
Chapter 4. Global Pet Cancer Therapeutics Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Pet Cancer Therapeutics Market, by Therapy
a. Market Snapshot
- 5.1. Global Pet Cancer Therapeutics Market by Therapy, Performance - Potential Analysis
- 5.2. Global Pet Cancer Therapeutics Market Estimates & Forecasts byTherapy 2018-2027 (USD Million)
- 5.3. Pet Cancer Therapeutics Market, Sub Segment Analysis
- 5.3.1. Chemotherapy
- 5.3.2. Radiation therapy
- 5.3.3. Immunotherapy
- 5.3.4. Others
Chapter 6. Global Pet Cancer Therapeutics Market, by Animal
- 6.1. Market Snapshot
- 6.2. Global Pet Cancer Therapeutics Market by Animal, Performance - Potential Analysis
- 6.3. Global Pet Cancer Therapeutics Market Estimates & Forecasts by Animal 2018-2027 (USD Million)
- 6.4. Pet Cancer Therapeutics Market, Sub Segment Analysis
- 6.4.1. Dogs
- 6.4.2. Cats
- 6.4.3. Others
Chapter 7. Global Pet Cancer Therapeutics Market, by Application
- 7.1. Market Snapshot
- 7.2. Global Pet Cancer Therapeutics Market by Application, Performance - Potential Analysis
- 7.3. Global Pet Cancer Therapeutics Market Estimates & Forecasts by Application 2018-2027 (USD Million)
- 7.4. Pet Cancer Therapeutics Market, Sub Segment Analysis
- 7.4.1. Lymphoma
- 7.4.2. Mast Cell Cancer
- 7.4.3. Melanoma
- 7.4.4. Mammary and Squamous Cell Cancer
- 7.4.5. Others
Chapter 8. Global Pet Cancer Therapeutics Market, Regional Analysis
- 8.1. Pet Cancer Therapeutics Market, Regional Market Snapshot
- 8.2. North America Pet Cancer Therapeutics Market
- 8.2.1. U.S.Pet Cancer Therapeutics Market
- 8.2.1.1. Therapy breakdown estimates & forecasts, 2018-2027
- 8.2.1.2. Animal breakdown estimates & forecasts, 2018-2027
- 8.2.1.3. Applicationbreakdown estimates & forecasts, 2018-2027
- 8.2.2. CanadaPet Cancer Therapeutics Market
- 8.2.1. U.S.Pet Cancer Therapeutics Market
- 8.3. Europe Pet Cancer Therapeutics Market Snapshot
- 8.3.1. U.K. Pet Cancer Therapeutics Market
- 8.3.2. Germany Pet Cancer Therapeutics Market
- 8.3.3. France Pet Cancer Therapeutics Market
- 8.3.4. Spain Pet Cancer Therapeutics Market
- 8.3.5. Italy Pet Cancer Therapeutics Market
- 8.3.6. Rest of EuropePet Cancer Therapeutics Market
- 8.4. Asia-PacificPet Cancer Therapeutics Market Snapshot
- 8.4.1. China Pet Cancer Therapeutics Market
- 8.4.2. India Pet Cancer Therapeutics Market
- 8.4.3. JapanPet Cancer Therapeutics Market
- 8.4.4. Australia Pet Cancer Therapeutics Market
- 8.4.5. South Korea Pet Cancer Therapeutics Market
- 8.4.6. Rest of Asia PacificPet Cancer Therapeutics Market
- 8.5. Latin America Pet Cancer Therapeutics Market Snapshot
- 8.5.1. Brazil Pet Cancer Therapeutics Market
- 8.5.2. Mexico Pet Cancer Therapeutics Market
- 8.6. Rest of The World Pet Cancer Therapeutics Market
Chapter 9. Competitive Intelligence
- 9.1. Top Market Strategies
- 9.2. Company Profiles
- 9.2.1. AB Science
- 9.2.1.1. Key Information
- 9.2.1.2. Overview
- 9.2.1.3. Financial (Subject to Data Availability)
- 9.2.1.4. ProductSummary
- 9.2.1.5. Recent Developments
- 9.2.2. AdvaVet Inc.
- 9.2.3. Boehringer Ingelheim GmbH (Merial)
- 9.2.4. Elanco
- 9.2.5. ELIAS Animal Health
- 9.2.6. Karyopharm Therapeutics, Inc.
- 9.2.7. Rhizen Pharmaceuticals SA
- 9.2.8. Torigen Pharmaceuticals Inc.
- 9.2.9. VetDC Inc.
- 9.2.10. Virbac
- 9.2.1. AB Science
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- 10.3. Research Assumption
LIST OF TABLES
- TABLE 2. Global Pet Cancer Therapeutics Market, report scope
- TABLE 3. Global Pet Cancer Therapeutics Market estimates & forecasts by region 2018-2027 (USD Million)
- TABLE 4. Global Pet Cancer Therapeutics Market estimates & forecasts by Therapy2018-2027 (USD Million)
- TABLE 5. Global Pet Cancer Therapeutics Market estimates & forecasts by Animal2018-2027 (USD Million)
- TABLE 6. Global Pet Cancer Therapeutics Market estimates& forecasts by Application 2018-2027 (USD Million)
- TABLE 7. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 8. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 9. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 10. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 11. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 12. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 13. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 14. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 15. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 16. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 17. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 18. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 19. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 20. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 21. Global Pet Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 22. Global Pet Cancer Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Million)
- TABLE 23. U.S. Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 24. U.S. Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 25. U.S. Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 26. Canada Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 27. Canada Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 28. Canada Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 29. UK Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 30. UK Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 31. UK Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 32. Germany Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 33. Germany Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 34. Germany Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 35. FrancePet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 36. FrancePet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 37. FrancePet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 38. SpainPet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 39. SpainPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 40. SpainPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 41. ItalyPet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 42. ItalyPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 43. ItalyPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 44. ROE Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 45. ROE Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 46. ROE Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 47. China Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 48. China Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 49. China Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 50. India Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 51. India Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 52. India Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 53. Japan Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 54. Japan Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 55. Japan Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 56. AustraliaPet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 57. AustraliaPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 58. AustraliaPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 59. South KoreaPet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 60. South KoreaPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 61. South KoreaPet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 62. ROPAC Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 63. ROPAC Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 64. ROPAC Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 65. Brazil Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 66. Brazil Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 67. Brazil Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 68. Mexico Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 69. Mexico Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 70. Mexico Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 71. ROLA Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 72. ROLA Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 73. ROLA Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 74. ROW Pet Cancer Therapeutics Market estimates & forecasts, 2018-2027 (USD Million)
- TABLE 75. ROW Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 76. ROW Pet Cancer Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Million)
- TABLE 77. List of secondary sources used in the study of global Pet Cancer Therapeutics Market.
- TABLE 78. List of primary sources used in the study of global Pet Cancer Therapeutics Market.
- TABLE 79. Years considered for the study.
- TABLE 80. Exchange rates considered.
LIST OF FIGURES
- FIG 1. Global Pet Cancer Therapeutics Market, research methodology
- FIG 2. Global Pet Cancer Therapeutics Market, market estimation techniques
- FIG 3. Global market size estimates & forecast methods
- FIG 4. Global Pet Cancer Therapeutics Market, key trends 2020
- FIG 5. Global Pet Cancer Therapeutics Market, growth prospects 2021-2027
- FIG 6. Global Pet Cancer Therapeutics Market, porters 5 force model
- FIG 7. Global Pet Cancer Therapeutics Market, pest analysis
- FIG 8. Global Pet Cancer Therapeutics Market, value chain analysis
- FIG 9. Global Pet Cancer Therapeutics Market by segment, 2018 & 2027 (USD Million)
- FIG 10. Global Pet Cancer Therapeutics Market by segment, 2018 & 2027 (USD Million)
- FIG 11. Global Pet Cancer Therapeutics Market by segment, 2018 & 2027 (USD Million)
- FIG 12. Global Pet Cancer Therapeutics Market by segment, 2018 & 2027 (USD Million)
- FIG 13. Global Pet Cancer Therapeutics Market by segment, 2018 & 2027 (USD Million)
- FIG 14. Global Pet Cancer Therapeutics Market by segment, 2018 & 2027 (USD Million)
- FIG 15. Global Pet Cancer Therapeutics Market by segment, 2018 & 2027 (USD Million)
- FIG 16. Global Pet Cancer Therapeutics Market by segment, 2018 & 2027 (USD Million)
- FIG 17. Global Pet Cancer Therapeutics Market, regional snapshot 2018 & 2027
- FIG 18. North America Pet Cancer Therapeutics Market2018 & 2027 (USD Million)
- FIG 19. Europe Pet Cancer Therapeutics Market2018 & 2027 (USD Million)
- FIG 20. Asia-Pacific Pet Cancer Therapeutics Market2018 & 2027 (USD Million)
- FIG 21. Latin America Pet Cancer Therapeutics Market2018 & 2027 (USD Million)
- FIG 22. Global Pet Cancer Therapeutics Market, company market share analysis (2020)
